Trial Profile
A Randomized, Parallel-controlled, Exploratory Clinical Trial of Second-line Chemotherapy With Second-line Chemotherapy Versus Second-line Chemotherapy With Apatinib in the Treatment of Metastatic Colorectal Cancer
Status:
Not yet recruiting
Phase of Trial:
Phase II
Latest Information Update: 02 Mar 2021
Price :
$35
*
At a glance
- Drugs Rivoceranib (Primary) ; Fluorouracil; Irinotecan; Oxaliplatin
- Indications Colorectal cancer
- Focus Therapeutic Use
- 17 Jan 2018 New trial record